Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-21-044668
Filing Date
2021-08-16
Accepted
2021-08-16 16:41:24
Documents
16
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A acet-10ka_20201231.htm   iXBRL 10-K/A 181317
2 EX-23.2 acet-ex232_7.htm EX-23.2 1862
3 EX-31.1 acet-ex311_8.htm EX-31.1 21284
4 EX-31.2 acet-ex312_9.htm EX-31.2 21266
5 EX-32.1 acet-ex321_6.htm EX-32.1 10471
  Complete submission text file 0001564590-21-044668.txt   439415

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA acet-20201231.xsd EX-101.SCH 5780
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE acet-20201231_lab.xml EX-101.LAB 29130
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acet-20201231_pre.xml EX-101.PRE 17505
9 EXTRACTED XBRL INSTANCE DOCUMENT acet-10ka_20201231_htm.xml XML 6034
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38359 | Film No.: 211179131
SIC: 2834 Pharmaceutical Preparations